Position in DYN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,173,591
+$3,488,332 QoQ
Shares Held
187,915
+397.2% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 245 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. DYN ranks #75 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,173,591 | 187,915 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $685,259 | 37,797 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $717,010 | 36,657 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $422,318 | 33,385 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $585,736 | 61,527 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,039,227 | 194,955 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,367,124 | 142,917 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,314,612 | 64,438 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,295,601 | 36,713 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $8,520,604 | 300,127 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $952,332 | 71,604 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $554,578 | 61,895 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $566,853 | 50,387 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $51,206 | 4,445 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $117,858 | 10,169 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,607,540 | 126,578 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,766,246 | 402,656 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $71,586 | 7,426 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $165,496 | 13,919 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $61,565 | 3,791 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $39,513 | 1,878 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $16,586 | 1,068 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $55,839 | 2,659 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||